UK markets close in 1 hour 31 minutes

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.36+0.16 (+2.58%)
As of 09:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.20
Open6.36
Bid6.07 x 1200
Ask6.48 x 800
Day's range6.36 - 6.36
52-week range5.50 - 8.98
Volume211
Avg. volume15,167
Market cap69.863M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.20
Earnings date09 May 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est15.00
  • Business Wire

    LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System

    ORLANDO, Fla., June 13, 2022--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced U.S. Food and Drug Administration ("FDA") 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System ("ALLY" or "ALLY System"). ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the femtosecond-laser-assisted cataract sur

  • Simply Wall St.

    Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago

    Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you...

  • Business Wire

    LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update

    ORLANDO, Fla., May 09, 2022--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2022 and provided an update on operational initiatives.